arXiv:2601. 00175v2 Announce Type: replace Abstract: Objective: Develop and evaluate machine learning (ML) models for predicting incident liver cirrhosis (LC) one and two years prior to diagnosis using routinely collected electronic health record (EHR) data and benchmark their performance against the FIB-4 and APRI clinical scores.
By Zhuqi Miao, Ahmed G Qasem, Sujan Ravi, Jason T. Cheng, Abdulaziz Ahmed, Courtney W. Houchen, Sumayah Abed, Dilorom Azimdjanovna Zuparova, Abdulaziz Ahmed
Hepatitis C is a liver infection caused by a virus, which results in mild to severe inflammation of the liver. Over many years, hepatitis C gradually damages the liver, often leading to permanent scarring, known as cirrhosis.
arXiv:2606. 26561v1 Announce Type: new Abstract: Hepatitis C is a liver infection caused by a virus, which results in mild to severe inflammation of the liver.
By Abrar Alotaibi, Lujain Alnajrani, Nawal Alsheikh, Alhatoon Alanazy, Salam Alshammasi, Meshael Almusairii, Shoog Alrassan, Aisha Alansari
The study evaluates several machine‑learning classifiers for predicting heart disease using two public datasets, each with 14 health‑related attributes. Performance metrics such as MAE, RAE, accuracy, precision, recall, and F‑measure were used, revealing that SVM performed best on the UCI data while Simple Cart excelled on the Kaggle data. The authors conclude that well‑tuned ML models can aid early heart‑disease diagnosis and suggest future work on hybrid methods and newer datasets.
By Sami Ullah, Muhammad Mohsin Khan
arXiv:2606. 09860v1 Announce Type: cross Abstract: Non-alcoholic fatty liver disease (NAFLD) affects roughly 25% of global adults, posing substantial hepatic and cardiovascular risks.
By Xinze Zhang
arXiv:2607. 25348v1 Announce Type: cross Abstract: Chronic Kidney Disease (CKD), characterized by the gradual loss of kidney function, remains a significant public health challenge.
By Md Zahid Hasan Ontor, Md Al Amin, Anik Dev Nath, Bikash Kumar Paul
arXiv:2609.13192v1 Announce Type: new
Abstract: This study compares traditional machine learning models and Large Language Model (LLM)-generated rule-based systems for heart disease prediction using...
By Feisal Alaswad, Batoul Aljaddouh, Maher Alrahhal, Wafaa Al Nassan, Talal Bonn
arXiv:2601.00175v3 Announce Type: replace
Abstract: Objective: Develop and evaluate machine learning (ML) models for predicting incident liver cirrhosis (LC) one and two years before diagnosis using...
By Zhuqi Miao, Ahmed G Qasem, Sujan Ravi, Jason T. Cheng, Abdulaziz Ahmed, Courtney W. Houchen, Sumayah Abed, Dilorom Azimdjanovna Zuparova, Abdulaziz Ahmed
arXiv:2604. 23954v2 Announce Type: replace Abstract: Artificial Intelligence (AI) and Machine Learning (ML) models used in clinical settings are increasingly deployed to support clinical decision-making.
By Ioannis Bilionis, Ricardo C. Berrios, Luis Fernandez-Luque, Carlos Castillo
arXiv:2607. 08299v1 Announce Type: new Abstract: Accurate and timely diagnoses are essential for quality patient care.
By Abu Rafe Md Jamil, Nayan Malakar
arXiv:2605. 19208v2 Announce Type: replace-cross Abstract: Physical activity (PA) plays an important role in maintaining and improving health.
By Gefei Lin, Rui Miao, Jennifer Sacheck, Xiaoke Zhang
This study investigates deep learning and explainable AI methods to diagnose hepatocellular carcinoma (HCC) and identify diagnostic and prognostic biomarkers across five disease stages using a transcriptomic dataset built via semi‑supervised learning. The best model used 15 genes selected by SelectKBest, achieving 90.74% accuracy, while a 20‑gene model had the lowest loss of 0.3187. SHAP‑based XAI highlighted DNAJB14 as the most influential gene, and functional validation showed that inhibiting DNAJB14 reverses key malignant traits of HCC cells.
By Ali Bou Nassif, Darko Castven, Manar Abu Talib, Jibran Sualeh Muhammad, Ahmed Ammar Kubba, Jens Marquardt, Abdalla Sayed Ali